Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets

• Status: Completed
• Trial end date: 2008-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the optimal dosage of the clinical trial which is evaluating the antihypertensive efficacy and the safety of OJP-2028 tablets in patients with the uncomplicated essential hypertension.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Jeil Pharmaceutical Co., Ltd.
• Treatments: Antihypertensive Agents

Criteria

Inclusion Criteria:

1. Adult men and women (Age 18-75 years)

2. Uncomplicated essential hypertension: Clinic sitting SiDBP between 90 and 109 mmHg after 2 week placebo run-in period

Exclusion Criteria:

1. Secondary hypertension

2. History and/or signs of cardiovascular complications (eg; myocardial infarction, unstable angina)

3. Pregnancy or lactation

4. Contraindications to the antihypertensive drugs to be used during the treatment period